PPT-10-year trend of the annual rate of measles and rubella suspected cases. Latin America

Source ISIS MESS and country reports Data as of 1 May 2023 N 18897 20064 18971 13009 13308 41663 91950 25693 9318 14927 Text In the last 10 years there was a downward trend in the notification rate of suspected measles and rubella cases reaching its lowest point in 2021 . Dr. Kimberly M. Thompson. 11. th. Annual Measles and Rubella Partners Meeting. September 19, 2012. Acknowledgments. World Health Organization (WHO) Contract PO 200470477 APW . Radboud. . Duintjer. . 11. th. Annual Meeting . Measles and Rubella Initiative. Washington, DC. Peter Strebel, WHO/EPI. The mission of the Decade of Vaccines is to extend, by 2020 and beyond, the full benefits of immunization to all people, regardless of where they are born, who they are, or where they live.". . Accelerating Progress towards Measles/Rubella Control and Elimination Goals Meeting. Geneva, Switzerland. June 19, 2016. Lance Rodewald. WHO China Country Office. Measles and Rubella Vaccination Schedule. Panel 01502. Vicki Stambos. The 13. th. Global Measles and Rubella Laboratory Network Meeting, Geneva, Switzerland, 29. th. June to 1. st. July 2015. Vicki Stambos. Accelerating Progress Towards Measles and Rubella Control and Elimination Meeting. 11. th. Annual Meeting . Measles and Rubella Initiative. Washington, DC. Peter Strebel, WHO/EPI. The mission of the Decade of Vaccines is to extend, by 2020 and beyond, the full benefits of immunization to all people, regardless of where they are born, who they are, or where they live.". Dr. Kimberly M. Thompson. 11. th. Annual Measles and Rubella Partners Meeting. September 19, 2012. Acknowledgments. World Health Organization (WHO) Contract PO 200470477 APW . Radboud. . Duintjer. . . Accelerating Progress towards Measles/Rubella Control and Elimination Goals Meeting. Geneva, Switzerland. June 19, 2016. Lance Rodewald. WHO China Country Office. Measles and Rubella Vaccination Schedule. 2020. . Summary of the . Findings . and Implementation Status . Dr Kaushik . Banerjee. M&RI Partners' Meeting. Washington DC. 7 September 2017. 1. Objectives . of . the Review. To provide a candid review of progress . Dr. Kimberly M. Thompson. 11. th. Annual Measles and Rubella Partners Meeting. September 19, 2012. Acknowledgments. World Health Organization (WHO) Contract PO 200470477 APW . Radboud. . Duintjer. . Definition of suspected measles and rubella case.  . Patient . with rash* with . two or more. of the following signs or symptoms:. fever, usually <38.5 ° C. conjunctivitis (non-purulent/hyperemic). 3.275. 1.447. 678. 70. 5.041. 64. 4.249. 101. 314. 359. 1.478. 130. 489. 784. 154. 243. SC: Suspected case. Source: Measles Elimination Surveillance System, Integrated Surveillance Information System and country reports to FPL-IM/PAHO.. Susan Reef, MD. , . and Joseph . P. Icenogle, PhD, colleagues. , . and other collaborators. Accelerating Progress towards Measles and Rubella Elimination,. 21-23 June 2016, Hotel Royal, Geneva. Background. Opening Comments & Perspectives. Dr. Suresh Jadhav. Executive Director. Serum Institute of India Pvt. Ltd.,. ssj@seruminstitute.com. . We, at Serum Institute of India Pvt. Ltd., feel proud of being a partner to PAHO / WHO in achieving what is designated to be a historical achievement in eradication of Measles & Rubella diseases from the Americas.. MMR1: first dose of measles, mumps and rubella vaccine. Haiti uses measles-rubella containing vaccine (MR). . Source: country reports sent to Immunization Unit, PAHO/WHO . *27 countries and 3 territories.